Pharmaceuticals - Community Register


List of nationally authorised medicinal products for human use

Risperdal Consta

Product name: Risperdal Consta
Also marketed in the EU under the name(s): Risperidon-Janssen Consta, Rispolept Consta, Rispolin Consta
Active substance: Risperidone
Indication: RISPERDAL CONSTA is indicated for the maintenance treatment of schizophrenia in patients currently stabilised with oral antipsychotics
Marketing Authorisation Holder: Not applicable

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
09/10/2008 Referral EMEA/H/A-30/912 (2008)5940 of 07/10/2008